The role of laboratory biomarkers in monitoring of rituximab biosimilar therapy (Acellbia, “BIOCAD”) in patients with rheumatoid arthritis
Avdeeva, A S, Cherkasova, M V, Kusevich, D A, Rybakova, V V, Artyuhov, A S, Dashinimaev, Eh B, Chichasova, N V, Nasonov, E L
Published in Terapevtic̆eskii arhiv (15.05.2019)
Published in Terapevtic̆eskii arhiv (15.05.2019)
Get full text
Journal Article
Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice
Kusevich, D. A., Avdeeva, A. S., Rybakova, V. V., Chichasova, N. V., Nasonov, E. L.
Published in Nauchno-prakticheskai͡a︡ revmatologii͡a (22.01.2019)
Published in Nauchno-prakticheskai͡a︡ revmatologii͡a (22.01.2019)
Get full text
Journal Article
Evaluation of rituximab therapy in real clinical practice (according to the OREL registry of patients with rheumatoid arthritis
Avdeeva, A. S., Satybaldyev, A. M., Demidova, N. V., Nikishina, N. Yu, Gerasimova, E. V., Muravyeva, N. V., Gridneva, G. I., Rumyantseva, O. A., Kasumova, K. A., Alekseeva, A. V., Chichasova, N. V., Kusevich, D. A., Rybakova, V. V., Koshkarova, E. A., Lila, A. M., Nasonov, E. L.
Published in Nauchno-prakticheskai͡a︡ revmatologii͡a (11.07.2019)
Published in Nauchno-prakticheskai͡a︡ revmatologii͡a (11.07.2019)
Get full text
Journal Article
Severe rheumatoid arthritis with multiple baseline anti-inflammatory drugs intolerance
D. A. Kusevich, G. R. Imametdinova, N. V. Chichasova, E. L. Nasonov
Published in Sechenovskiĭ vestnik (01.12.2022)
Get full text
Published in Sechenovskiĭ vestnik (01.12.2022)
Journal Article